NCT03804372 2025-02-27CLL1818Gruppo Italiano Malattie EMatologiche dell'AdultoPhase 2 Terminated5 enrolled
NCT01446900 2018-01-31R-2cda and Prolongation of Therapy With Rituximab Alone in Chronic Lymphocytic Leukaemia and Small Lymphocytic LymphomaEuropean Institute of OncologyPhase 2 Terminated25 enrolled